2008: SLE: Clinical Aspects III
Search or Browse by Day

SLE: Clinical Aspects III

Tuesday, October 28, 2008
1705
The BILAG2004-Pregnancy Index has Construct and Criterion Validity
1706
The BILAG2004-Pregnancy Index for Assessment of SLE Disease Activity in Pregnancy is Sensitive to Change
1707
The Relationship Between Childhood-Onset Disease and Mortality in a Large Cohort of Patients with Systemic Lupus Erythematosus
1708
Low Flare Rates and Favorable Fetal Outcomes in Lupus Pregnancies
1709
The increase of M1 chemokines in RHPS associated with SLE
1710
Predictors of Disease Activity Patterns over Time in a Multiethnic US Cohort of Patients with Systemic Lupus Erythematosus
1711
Renal Damage is the Most Important Predictor of Mortality within the Damage Index: Data from a Multiethnic US Lupus Cohort
1712
Non-invasive Monitoring Of Lupus Nephritis Using Urinary Protease
1713
Erythrocyte C4d Predicts a Future Diagnosis of SLE in Patients with Undifferentiated Connective Tissue Disease at Initial Visit
1714
Autoantibody Accrual Following SLE diagnosis in a Large Single Centre Lupus Cohort
1715
Anti Thyroid Antibodies Are Frequently Seen In Patients Referred To A Rheumatologist For Evaluation Of Positive ANA
1716
Efficacy of Procalcitonin to Determine Infection versus Lupus Flare in patients with Systemic Lupus Erhytematosus
1717
SLEDAI-2K Describing Features Over the Past 10 days and 30 days
1718
Prolonged Serologically Active Clinically Quiescent (SACQ) Systemic Lupus Erythematosus: Predictors Of Flare
1719
Prolonged Serologically Active Clinically Quiescent (SACQ) Systemic Lupus Erythematosus: Clinical And Serologic Features
1720
Multicenter Validation of the Self-Reported Lupus Damage Index Questionnaire (LDIQ)
1721
Anti-C1q as a Potential Marker of SLE Activity, Including Proteinuria
1722
The Relationship of Anti-C1q to the ACR Classification Criteria for SLE
1723
SLE Pregnancy: Global and Organ System-Specific Effects on Disease Activity
1724
Association of HLA-DRB1 with Susceptibility to and Clinical Manifestations of Systemic Lupus Erythematosus in Koreans
1725
A Randomized Clinical Trial to Enhance Adjustment and Disease Adaptation among Adolescent Females with Lupus
1726
Longitudinal Evaluation of Anti-La Idiotypic Antibodies in Mothers Enrolled in the PITCH Study
1727
Long-Term Outcome of Children Born to Mothers with SLE: A Pilot Project
1728
Baseline IFN-regulated chemokine levels are strong predictors of Systemic Lupus Erythematosus flare
1729
US Patient Derived Lupus-Specific Patient Reported Outcome Measure (Lupus-PRO©): Validity and Reliability
1730
Lupus Specific Health Outcome Measure for US Patients: The LupusQoL- US Version©
1731
Employment, Work Disability and Health Related Quality of Life in Systemic Lupus Erythematosus
1732
Protein Z Gene Polymorphisms in Systemic Lupus Erythematosus
1733
The Impact of Smoking Status on SLE Clinical Course
1734
Osteoporosis And Risk Factors In Women With Systemic Lupus Erythematosus (SLE): A Case-control Study
1735
Prevalence of Premature Menopause and Associated Factors in Systemic Lupus Erythematosus (SLE)
1736
The Influence of Cigarette Smoking on Autoantibodies in SLE
1737
Atorvastatin to Prevent Avascular Necrosis of Bone in Systemic Lupus Erythematosus
1738
The Association Of Early Family Characteristics With Adult-onset Systemic Lupus Erythematosus (SLE)
1739
Determinants of Adherence to Therapy in Systemic Lupus Erythematosus
1740
Predictors and Functional Impact of Lupus Lung Disease
1741
Treatment adherence in SLE
1743
Decreased Risk of Anti-Ro/La Associated Congenital Heart (CHB) In Fetuses Exposed to Hydroxychloroquine (HCQ)
1744
Skin Manifestations of Lupus Erythematosus: a Cohort of 119 Prospectively Enrolled Patients
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>